TOCE

The test uses the company's TOCE primer technology for multiplexed real-time PCR and is the first product Seegene has taken through the FDA.

Seegene will manufacture reagents designed exclusively for Beckman Coulter's new Veris MDx sample-to-answer molecular diagnostics system.

CHICAGO (GenomeWeb) — Seegene this week plans to submit its first molecular diagnostic test for US Food and Drug Administration clearance, an assay for herpes simplex virus I and II that uses the company's TOCE primer technology for multiplexed real-time PCR.

Seegene and Eidia, the in vitro diagnostics subsidiary of Japanese pharmaceutical firm Eisai, have entered into a collaborative agreement to bring new multiplex molecular diagnostic tests to Japan.

Seegene said this week that BioMérieux has licensed its DPO and TOCE technologies to develop multiplexed molecular tests for food safety.

Seegene this week fully unveiled its newest technology, a PCR chemistry that may enable real-time PCR-based detection and quantification of up more than 20 analytes from a single sample and in a single tube using existing multiplex-enabled thermal cyclers.

Molecular diagnostics and assay technology developer Seegene said this week that it has added yet another multiplex PCR-based chemistry to its portfolio of nucleic acid amplification, detection, and quantification technologies.

Seegene and DuPont Nutrition & Health said today that they have inked an agreement to jointly develop highly multiplexed assays to detect foodborne pathogens by combining Seegene's real-time PCR and melt curve analysis technology with DuPont's benchtop BAX System.

Seegene this week introduced the Anyplex II STI-7 detection assay, a multiplex real-time PCR assay for several sexually transmitted infectious agents.

Seegene in the coming week will unveil a new technology that enables highly multiplexed melt curve analysis on existing commercial real-time PCR instruments.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.